Dr. John Jones, MD (he/him) is an Endocrinologist in Gainesville, FL with over 16 years of experience. What is your opinion of Dr. John Jones, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. John Jones, MD has received over $17,979 which includes payments from the following companies:
$8,477.71 from AstraZeneca Pharmaceuticals LP
$3,927.66 from Takeda Pharmaceuticals America, Inc.
$2,632.13 from Takeda Pharmaceuticals U.S.A., Inc.
$2,022.67 from Novo Nordisk Inc
$326.42 from sanofi-aventis U.S. LLC
$130.84 from Janssen Pharmaceuticals, Inc
$120.96 from GlaxoSmithKline, LLC.
$75.92 from LILLY USA, LLC
$62.22 from AbbVie, Inc.
$58.75 from Medtronic MiniMed, Inc.
$19.24 from Shire North American Group Inc
$15.67 from Auxilium Pharmaceuticals, Inc.
$15.26 from Aegerion Pharmaceuticals, Inc.
$15.00 from Eisai Inc.
$14.99 from Daiichi Sankyo Inc.
$14.67 from Abbott Laboratories
$13.36 from Salix Pharmaceuticals, Ltd
$12.88 from Boehringer Ingelheim Pharmaceuticals, Inc.
$12.23 from Merck Sharp & Dohme Corporation
$10.75 from INSULET CORPORATION
Payments received by Dr. John Jones, MD were from the following categories:
$9,000.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!